Omicron -Covid-19 Variant

The ongoing Russia Ukraine conflict sees the first thing that you have to understand is the tension between Russia and Ukraine primarily because of two reasons one Ukraine is a matter of strategic importance to Russia look at the size of Ukraine it is a big country that is right in between the European Union and Russia so this is very straightforward and I will describe more about it in a while and the second reason is there is also a territorial conflict between Russia and Ukraine as you may know currently Russia is in control of Crimea and then there are two regions on eastern Ukraine which are called disks and Luhansk so these together combine to form Donbas region of eastern Ukraine so Ukraine was once part of the Soviet Union after Ukraine became a separate country and declared itself an independent country.   As you can see from this map Ukraine shares borders with both the European Union and Russia but as a former soviet republic it has deep social and cultural ties with...

  We have very little knowledge about the omicron variant  b11529 but we're starting to learn how it's bad.   Virus Name                       :                CoronaVirus Variant Name                   :                   Omicron (B.1.1.529) Detected Region              :                  South Africa Detected On                    :          ...

There are more than 2.8 million confirmed cases of coronavirus worldwide now, and more than 50 countries have reported at least 1,000 deaths related to COVID-19. The World Health Organization (WHO) also reports over 879,000 patients have lost their lives till and nearly 14.7 million people and businesses have been affected by this disease. Despite the severe toll from COVID-19 across the globe, it appears that vaccines could potentially provide protection against the new SARS-CoV-2 variant causing a range of symptoms. Pfizer’s, Modern a’s, and AstraZeneca’s, among others, are the Vaccines currently being used in the U.S.    Research shows on COVID-19 vaccines is still quite limited, with only about 15% of scientists participating in clinical trials and Phase 3 studies (test results that involve many participants) reporting a successful vaccine efficacy. This does not mean that there will be no success in developing new products for prevention. Several recent publications show ...